Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.
about
Commonalities in the Association between PPARG and Vitamin D Related with Obesity and CarcinogenesisIntegration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cellsTranscription factor co-repressors in cancer biology: roles and targetingEpigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancerGestational diabetes mellitus upregulates vitamin D receptor in extravillous trophoblasts and fetoplacental endothelial cellsEpigenetic distortion to VDR transcriptional regulation in prostate cancer cells.Identification of mRNA isoform switching in breast cancer.Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.Vitamin D receptor and RXR in the post-genomic era.VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcriptionConvergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.Nuclear receptors and the Warburg effect in cancer.Pan-cancer analyses of the nuclear receptor superfamilyCK2-NCoR signaling cascade promotes prostate tumorigenesisCooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.Targeting transcription factor corepressors in tumor cells.Peroxisome proliferator-activated receptor and vitamin d receptor signaling pathways in cancer cells.The multifaceted factor peroxisome proliferator-activated receptor γ (PPARγ) in metabolism, immunity, and cancer.LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.Transcriptional corepressors in cancer: emerging targets for therapeutic intervention.Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
P2860
Q28070220-0E7482D3-EB4A-4444-A39E-B72328008430Q31159857-4BB21562-5A21-4C05-B40D-02172043B206Q33563699-721E0E8B-284E-4DEE-BD06-B47832BA5E1EQ33762000-2A621996-AE92-406F-84E4-FDDBD81D67DBQ34723871-5E7A5034-F588-4A31-8879-B5A81FC8C126Q35079955-D073C2E6-DEA8-4F01-88DD-489DEFDF9220Q35155086-E2B89AA4-52B3-424D-A8E5-C5DA7C60B2B4Q35600481-C9C01612-3E30-49B5-9564-BC3D57F8C068Q35945158-B957BE4A-ABAA-4BAC-90F1-452351AB0237Q36002405-318BF6D9-D86F-45F2-8B08-A2F4678A3A7AQ36071737-BF0248BE-6C26-4F16-9AF0-8C1725F93D3BQ36216675-1DA303A9-69DC-4576-91ED-5F598D54C932Q36505841-E2FEA30B-082E-455D-8896-92324BAE1BFBQ36587617-EFFF0904-A81D-4F8F-8FC8-7821C97E1D66Q36683880-07F85F98-027A-49CD-A7C6-1C22C2EC9760Q36907762-C548749B-4F3F-45B5-AAEE-6B1359042C6FQ37138534-932AC2B8-D1F8-438B-A336-22220C1A5E0AQ37537548-4C605834-056E-4697-A6F4-DDDC9CBCD39AQ38004930-6283FF46-5AA8-4158-BA01-17B016F2060AQ38160745-2B318791-0544-45FF-BBF1-F147E7E999BFQ38314756-8CA57D19-E51C-4B62-8173-9F8796652621Q38622843-32E1F810-544F-4FAA-96A2-F81887B3AF16Q38788726-737742B1-9C40-451C-9CD3-6A11B12D8963Q44917007-6F2989B4-E784-426B-8CF1-EB1ABFEDD11FQ45949365-F6B8952E-E5A3-4EB3-B16A-818AC55F7AF6Q52715797-E4EC9C2A-F23C-483B-96D1-9C4A3163F5B7
P2860
Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@ast
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@en
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@nl
type
label
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@ast
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@en
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@nl
prefLabel
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@ast
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@en
Elevated NCOR1 disrupts PPARal ...... targetable epigenetic lesion.
@nl
P2093
P2860
P50
P356
P1433
P1476
Elevated NCOR1 disrupts PPARal ...... a targetable epigenetic lesion
@en
P2093
Christopher J McCabe
Colin S Cooper
Farhat L Khanim
Henry S O Coulter
Lara E Sucheston
Laura B Hornung
Laura P O'Neill
Lyndon M Gommersall
Moray J Campbell
Orla Maguire
P2860
P304
P356
10.1093/CARCIN/BGQ086
P407
P577
2010-05-13T00:00:00Z